Treating idiopathic intracranial hypertension--reply

Affiliations

¹ Department of Neurology, University of Iowa, Iowa City.
² School of Medicine and Dentistry, University of Rochester, Rochester, New York.
³ Department of Neurology, University of Rochester Medical Center, Rochester, New York.
⁴ Division of Neuro-Ophthalmology, Roosevelt Hospital, New York, New York.

Comment

Michael Wall et al. JAMA Neurol. 2014 Oct.

. 2014 Oct;71(10):1327-8.

doi: 10.1001/jamaneurol.2014.2363.

¹ Department of Neurology, University of Iowa, Iowa City.
² School of Medicine and Dentistry, University of Rochester, Rochester, New York.
³ Department of Neurology, University of Rochester Medical Center, Rochester, New York.
⁴ Division of Neuro-Ophthalmology, Roosevelt Hospital, New York, New York.

No abstract available

Comment on

The idiopathic intracranial hypertension treatment trial: clinical profile at baseline.
Wall M, Kupersmith MJ, Kieburtz KD, Corbett JJ, Feldon SE, Friedman DI, Katz DM, Keltner JL, Schron EB, McDermott MP; NORDIC Idiopathic Intracranial Hypertension Study Group. Wall M, et al. JAMA Neurol. 2014 Jun;71(6):693-701. doi: 10.1001/jamaneurol.2014.133. JAMA Neurol. 2014. PMID: 24756302 Free PMC article. Clinical Trial.
Treating idiopathic intracranial hypertension.
Mollan SP, Burdon MA, Sinclair AJ. Mollan SP, et al. JAMA Neurol. 2014 Oct;71(10):1326-7. doi: 10.1001/jamaneurol.2014.2360. JAMA Neurol. 2014. PMID: 25322316 No abstract available.